APA and PAS Training for Gait Initiation in Parkinson's Disease - Trial NCT06363071
Access comprehensive clinical trial information for NCT06363071 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung University and is currently Recruiting. The study focuses on Parkinson Disease. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung University
Timeline & Enrollment
N/A
Jun 13, 2022
May 31, 2025
Primary Outcome
Balance Performance,COP Path Length in Balance Tasks,COP Displacement in Balance Tasks,Motor Evoked Potentials (MEPs),Intracortical Facilitation (ICF),Intracortical Inhibition (ICI),Walking Speed,Step Length,Step Time
Summary
Our research focused on understanding the interplay between brain excitability and balance
 function in patients with Parkinson's disease (PD), alongside evaluating effective physical
 therapy methods. It highlights the prevalence of non-motor disorders and cognitive
 impairments among PD patients, including balance and postural issues, cognitive function
 decline, and gait instability. Additionally, it notes that PD patients exhibit abnormal
 electrophysiological responses, indicating altered central excitability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06363071
Non-Device Trial